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Cytomegalovirus infection is associated with cytoskeletal alterations and cell swelling (cytomegaly), which
have been attributed to the viral mitochondria-localized inhibitor of apoptosis (vMIA) protein. In a recent issue
ofScience, Seo et al. (2011) showed that the antiviral host protein viperin is co-opted to function with vMIA for
facilitating infection.Viral genomes are small and encode
a limited number of proteins. Thus, most
steps of the viral cycle involve the com-
plex interaction between a few viral com-
ponents and a large number of host
factors. These include proteins that oper-
ate to protect cells against infection, but
also factors that are co-opted by viruses
for increasing infectivity or facilitating viral
spreading (Galluzzi et al., 2008). In a
recent issue of Science, Seo et al. (2011)
provided evidence suggesting that vi-
perin, an interferon-inducible host protein
with antiviral activity, is recruited by the
viral mitochondria-localized inhibitor of
apoptosis (vMIA) protein to facilitate
human herpesvirus-5 (HHV-5) infection.
Cells infected by HHV-5, a member
of the Herpesviridae family, are rapidly
affected by a generalized disruption of
the actin cytoskeleton, which eventually
leads to a massive enlargement of the cell
known as cytomegaly. Although strate-
gies that inhibit viral replication frequently
also reduce cytomegaly, its significance
for viral infectivity remains unclear. Owing
to this characteristic cytopathic effect of
cell swelling, HHV-5 is best known as
human cytomegalovirus (HCMV). HCMV
generally behaves as an opportunistic
pathogen and establishes persistent in-
fections that, in immunocompetent hosts,
do notmanifest at the clinical level. Never-
theless, HCMV can cause colitis, retinitis,
and encephalitis in immunodeficient indi-
viduals and in utero (Gandhi and Khanna,
2004).
The HCMV genome encodes at least
twoproteins that inhibit cell death: the viral
inhibitor of caspase-8 activation (pUL36,vICA) and vMIA (pUL37x1). vICA report-
edly prevents the activation of caspase-8,
thereby blocking death receptor-medi-
ated extrinsic apoptosis (Skaletskaya
et al., 2001). Conversely, vMIA exerts cy-
toprotective functions by sequestering
and neutralizing the proapoptotic BCL-2
familymemberBAX, an essentialmediator
of intrinsic apoptosis (Pauleau et al.,
2007). Notably, vMIA-deficient HCMV
strains fail to replicate in normal cells (as
these succumb to apoptosis), yet they
complete the viral cycle in cells that over-
express antiapoptotic BCL-2-like proteins
such as E1B19K (Reboredo et al., 2004).
Thus, vMIA allows HCMV to circumvent
one of the most ancient lines of defense
against infection, the induction of pro-
grammed cell death (Galluzzi et al., 2008;
Kroemer et al., 2007).
The role of vMIA in the molecular mech-
anisms by which HCMV induces cytome-
galy was uncovered by the observation
that transgene-driven expression of vMIA
in human cervical carcinoma cells and
murine fibroblasts recapitulated the early
cytopathic effects of HCMV infection,
namely a cell size reduction coupled to
actin depolymerization and cell rounding
(Poncet et al., 2006). vMIA-expressing
cells exhibited alterations in readherence
upon detachment, as well as in motility
(as assessed by wound healing tests),
but this was neither secondary to defects
in the signaling pathways that regulate
actin rearrangement (such as the molec-
ular cascade controlled by the small
GTPase Rho) nor linked to the antiapop-
totic functions of vMIA (as it persisted in
BAX-deficient cells) (Poncet et al., 2006).Developmental CellIn line with the fact that the mitochondrial
network of cells expressing vMIA was
highly fragmented, these cells exhibited
a major reduction in mitochondrial respi-
ration and in their capacity to synthesize
ATP (Poncet et al., 2006). This phenom-
enon was attributed to the interaction of
vMIA with the mitochondrial phosphate
carrier (PiC), a component of the ATP syn-
thasome. PiC knockdown or ATP deple-
tion by oligomycin (an inhibitor of the
F1FO-ATP synthase), rotenone (an inhib-
itor of respiratory complex I), or TTFA
(which inhibits respiratory complex II) re-
capitulated the cytoskeletal alterations
induced by vMIA expression, demon-
strating that the cytopathic effects of
HCMV infection result from a vMIA-medi-
ated bioenergetic crisis entailing PiC inhi-
bition and reduced ATP availability
(Figure 1A) (Poncet et al., 2006).
Seo et al. (2011) now add a twist to the
understanding of HCMV infectious pro-
cess by reporting that the host protein
viperin operates downstream of vMIA in
the molecular cascade that bridges
HCMV infection to ATP depletion and cy-
tomegaly. Interferon-induced viperin, an
iron-sulfur (Fe-S) cluster-binding protein
that has recently been ascribedwith enzy-
matic functions (Duschene andBroderick,
2010), localizes to the endoplasmic retic-
ulum (ER), from where it inhibits the repli-
cation of multiple viral strains, including
HCMV (Chin and Cresswell, 2001). How-
ever, viperin is also directly induced by
HCMV infection (Chin and Cresswell,
2001), for reasons that until now have re-
mained obscure. Seo et al. (2011) now
demonstrate that early during the viral20, June 14, 2011 ª2011 Elsevier Inc. 737
Figure 1. Mechanisms Underlying HMCV-Induced Cytomegaly
(A) The HCMV-encoded viral mitochondria-localized inhibitor of apoptosis (vMIA) is found at the mitochondrial outer membrane (OM), from where it sequesters
the proapoptotic BCL-2 family member BAX in an inactive conformation and inhibits the mitochondrial phosphate carrier (PiC), a component of the ATP syntha-
some. This limits the availability of inorganic phosphate (Pi) in the mitochondrial matrix, thus impairing ATP synthesis.
(B) In addition, vMIA has been shown to recruit to mitochondria viperin, an interferon-responsive protein that is also upregulated during HMCV infection. Mito-
chondrial viperin physically interacts with a subunit (HADHB) of the mitochondrial trifunctional protein (TFP), inhibiting b-oxidation and hence causing a decrease
in both ATP and NADH levels. ANT, adenine nucleotide translocase; IM, mitochondrial inner membrane; IMS, mitochondrial intermembrane space.
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mitochondria owing to a physical interac-
tion between its N terminus and vMIA.
Mitochondrial viperin, be it recruited by
vMIA or directed there by the addition
of a mitochondrial localization sequence
(MLS), appears to bind and inhibit the
b subunit (HADHB) of the mitochondrial
trifunctional protein (TFP), a multienzyme
complex that catalyzes at least three
steps of fatty acid b-oxidation (Seo
et al., 2011). The inhibitory binding of
viperin to HADHB is dependent on its
Fe-S cluster (as it was abolished by two
cysteine-to-alanine mutations that render
viperin unable to associate with Fe-S
clusters) and has dramatic bioenergetic
consequences, including reduced fatty
acid b-oxidation, doubled ADP/ATP
ratios, and lowered NADH/NAD+ ratios,
which are paralleled by the cytoskeletal
alterations that characterize cytomegaly
(Seo et al., 2011). Experiments involving
suitable genetic models—vMIA-deficient
HCMV strains and/or viperin-deficient
mouse embryonic fibroblasts (MEFs)—
demonstrated that while vMIA is required
for the bioenergetic and cytoskeletal
effects of wild-type (WT) viperin, it is
dispensable when viperin is targeted to
mitochondria by an MLS (Seo et al.,738 Developmental Cell 20, June 14, 2011 ª22011). Similarly, by taking advantage of
fibroblastsderived fromTFP-deficient indi-
viduals, Seo et al. (2011) concluded that
HADHB is required for the cytopathic
effects of viperin. Taken together, these
observations suggest that the cytopathic
effect of HCMV, cytomegaly, can be
ascribed to the bioenergetic crisis that
follows the vMIA-mediated recruitment of
endogenous viperin to mitochondria (Fig-
ure1B).Ofnote, viral replication is impaired
in viperin-deficient cells (Seo et al., 2011),
unequivocally demonstrating that the
induction of viperin by HCMV facilitates,
rather than inhibits, the infectious process.
Given that exogenous vMIA expression
appears to be sufficient to induce cyto-
skeletal disruption in HeLa cells (Poncet
et al., 2006), it is possible that HCMV
induces cytomegaly via two intertwined
and overlapping mechanisms, both of
which require vMIA expression (at least
in physiological contexts) and entail mito-
chondrial dysfunction and decreased ATP
availability, and only one of which is de-
pendent on viperin (Figure 1). Cell-intrinsic
variables, and in particular the extent of vi-
perin induction upon infection and the
metabolic profile (i.e., predominantly gly-
colytic or predominantly respiratory), are
very likely to influence the relative contri-011 Elsevier Inc.bution of these two pathways to the cyto-
pathic effects of HCMV. These aspects
await further investigation.
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